22,500
Participants
Start Date
September 1, 2021
Primary Completion Date
March 31, 2023
Study Completion Date
March 31, 2023
no intervention
no intervention
Department of Cardiology, Peking University First Hospital, Beijing
Collaborators (2)
China Cardiovascular Association
OTHER
AstraZeneca
INDUSTRY
Peking University First Hospital
OTHER